These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1715158)

  • 1. Heterogeneity of the antigenic site responsible for the induction of neutralizing antibodies in infectious bursal disease virus.
    Oppling V; Müller H; Becht H
    Arch Virol; 1991; 119(3-4):211-23. PubMed ID: 1715158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-neutralizing and passively protective monoclonal antibodies to infectious bursal disease virus of chickens.
    Fahey KJ; McWaters P; Brown MA; Erny K; Murphy VJ; Hewish DR
    Avian Dis; 1991; 35(2):365-73. PubMed ID: 1713030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of crucial residues of conformational epitopes on VP2 protein of infectious bursal disease virus by phage display.
    Cui X; Nagesha HS; Holmes IH
    J Virol Methods; 2003 Apr; 109(1):75-83. PubMed ID: 12668271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and structural bases for the antigenicity of VP2 of infectious bursal disease virus.
    Letzel T; Coulibaly F; Rey FA; Delmas B; Jagt E; van Loon AA; Mundt E
    J Virol; 2007 Dec; 81(23):12827-35. PubMed ID: 17881448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of infectious bursal disease viruses directly from infected tissues with neutralizing monoclonal antibodies: evidence of a major antigenic shift in recent field isolates.
    Snyder DB; Lana DP; Savage PK; Yancey FS; Mengel SA; Marquardt WW
    Avian Dis; 1988; 32(3):535-9. PubMed ID: 2461698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetic basis for the antigenicity of the VP2 protein of the infectious bursal disease virus.
    Schnitzler D; Bernstein F; Müller H; Becht H
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1563-71. PubMed ID: 7688411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States.
    Snyder DB; Vakharia VN; Savage PK
    Arch Virol; 1992; 127(1-4):89-101. PubMed ID: 1333761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of neutralizing antigens of recent isolates of infections bursal disease virus.
    Reddy SK; Silim A
    Arch Virol; 1991; 117(3-4):287-96. PubMed ID: 1850233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus.
    Becht H; Müller H; Müller HK
    J Gen Virol; 1988 Mar; 69 ( Pt 3)():631-40. PubMed ID: 2450966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope mapping of capsid proteins VP2 and VP3 of infectious bursal disease virus.
    Yamaguchi T; Iwata K; Kobayashi M; Ogawa M; Fukushi H; Hirai K
    Arch Virol; 1996; 141(8):1493-507. PubMed ID: 8856029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on antigenic relatedness of classic and variant strains of infectious bursal disease viruses.
    Ture O; Tsai HJ; Saif YM
    Avian Dis; 1993; 37(3):647-54. PubMed ID: 8257353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins.
    Vakharia VN; Snyder DB; Lütticken D; Mengel-Whereat SA; Savage PK; Edwards GH; Goodwin MA
    Vaccine; 1994 Apr; 12(5):452-6. PubMed ID: 8023554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited antigenic variation among recent infectious bursal disease virus isolates from France.
    Eterradossi N; Rivallan G; Toquin D; Guittet M
    Arch Virol; 1997; 142(10):2079-87. PubMed ID: 9413517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological roles of the major capsid proteins and relationships between the two existing serotypes of infectious bursal disease virus.
    Reddy SK; Silim A; Ratcliffe MJ
    Arch Virol; 1992; 127(1-4):209-22. PubMed ID: 1333752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence analysis and expression of the host-protective immunogen VP2 of a variant strain of infectious bursal disease virus which can circumvent vaccination with standard type I strains.
    Heine HG; Haritou M; Failla P; Fahey K; Azad A
    J Gen Virol; 1991 Aug; 72 ( Pt 8)():1835-43. PubMed ID: 1651980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimaeric VP2 proteins from infectious bursal disease virus containing the N-terminal M2e of H9 subtype avian influenza virus induce neutralizing antibody responses to both viruses.
    Tang Y; Gong Y; Wang Y; Wu P; Liu Y; Lu J; Gao F; Chen T; Hou F; Hou J
    Avian Pathol; 2013; 42(3):260-7. PubMed ID: 23607544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the antigenic, immunogenic, and pathogenic variation of infectious bursal disease virus due to propagation in different host systems (bursa, embryo, and cell culture). II. Antigenicity at the epitope level.
    Rodriguez-Chavez IR; Rosenberger JK; Cloud SS
    Avian Pathol; 2002 Oct; 31(5):473-83. PubMed ID: 12427341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-idiotypic antibody specific for an infectious bursal disease virus-neutralizing monoclonal antibody does not interfere with the virus infection.
    Yamaguchi T; Igusa A; Setiyono A; Fukushi H; Hirai K
    Arch Virol; 2002 Oct; 147(10):2017-23. PubMed ID: 12376762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of conformational epitopes on capsid protein VP2 of infectious bursal disease virus by fd-tet phage display.
    Cui X; Nagesha HS; Holmes IH
    J Virol Methods; 2003 Dec; 114(1):109-12. PubMed ID: 14599686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified activity of a VP2-located neutralizing epitope on various vaccine, pathogenic and hypervirulent strains of infectious bursal disease virus.
    Eterradossi N; Toquin D; Rivallan G; Guittet M
    Arch Virol; 1997; 142(2):255-70. PubMed ID: 9125042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.